Top Markets
Coin of the day
Gilead Sciences, Inc. Gilead Sciences, Inc.

Gilead Sciences, Inc.

GILD
株式のランク #93
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and... Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of liver diseases. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of hematology, oncology, and cell therapy patients. In addition, the company provides Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; Ranexa, an oral formulation for the treatment of chronic angina; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Gadeta B.V.; Bristol-Myers Squibb Company; Dragonfly Therapeutics, Inc.; and Merck & Co, Inc. The company was incorporated in 1987 and is headquartered in Foster City, California.
株価
$137.21
時価総額
$170.34B
変化(1日)
-2.76%
変化(1年)
28.14%
US
取引 Gilead Sciences, Inc. (GILD)

カテゴリー

Gilead Sciences, Inc.(GILD)のP/S比率
March 2026 時点のP/S比率 TTM: 6.11
Gilead Sciences, Inc. の最新の財務報告および株価によると、現在のP/S比率(TTM)は 6.11 です。2024 年末時点でのP/S比率は 4.01 でした。
Gilead Sciences, Inc. の P/S 比率の履歴(2000 ~ 2026)
各年末時点のP/S比率
P/S比率 変化
2026 (TTM) 6.11 17.79%
2025 5.19 29.46%
2024 4.01 7.44%
2023 3.73 -5.59%
2022 3.95 18.24%
2021 3.34 12.60%
2020 2.97 -19.31%
2019 3.68 0.19%
2018 3.67 2.31%
2017 3.59 13.67%
2016 3.16 -30.48%
2015 4.54 -21.25%
2014 5.76 -43.76%
2013 10.25 78.72%
2012 5.73 51.64%
2011 3.78 -3.10%
2010 3.90 -30.11%
2009 5.58 -36.72%
2008 8.82 -12.66%
2007 10.10 2.59%
2006 9.85 -16.34%
2005 11.77 3.14%
2004 11.41 -15.54%
2003 13.51 -5.12%
2002 14.24 -46.77%
2001 26.76 38.69%
2000 19.29 0.00%
同業他社のP/S比率
企業 P/S比率 P/S比率の差
14.26 133.21%
US
4.96 -18.85%
GB
6.18 1.07%
US
6.35 3.89%
US
5.18 -15.33%
CH